APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Darbepoetin Alpha Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Darbepoetin Alpha Injection Industry Growth and Trends Forecast to 2032

Report ID 173982600127 December 202598 pages

Choose your research edition.

Industry ResearchDarbepoetin Alpha Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Darbepoetin Alpha Injection Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Darbepoetin Alpha Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Darbepoetin Alpha Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Darbepoetin Alpha Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Darbepoetin Alpha Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Darbepoetin Alpha Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Darbepoetin Alpha Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Darbepoetin Alpha Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Darbepoetin Alpha Injection include Kyowa Kirin, Jiangsu Hengrui Medicine, Amgen, Torii Pharmaceutical, Qilu Pharmaceutical, Chugai Pharmaceutical and China Resources Double-Crane Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Darbepoetin Alpha Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Darbepoetin Alpha Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Darbepoetin Alpha Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Darbepoetin Alpha Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Darbepoetin Alpha Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Darbepoetin Alpha Injection Market by Company

Kyowa Kirin

Jiangsu Hengrui Medicine

Amgen

Torii Pharmaceutical

Qilu Pharmaceutical

Chugai Pharmaceutical

China Resources Double-Crane Pharmaceutical

Darbepoetin Alpha Injection Segment by Type

10ug/0.5mL

20ug/0.5mL

30ug/0.5mL

40ug/0.5mL

60ug/0.5mL

Darbepoetin Alpha Injection Segment by Application

Hospital

Clinic

Others

Darbepoetin Alpha Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Darbepoetin Alpha Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Darbepoetin Alpha Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Darbepoetin Alpha Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Darbepoetin Alpha Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Darbepoetin Alpha Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10ug/0.5mL Table 2. Major Company of 20ug/0.5mL Table 3. Major Company of 30ug/0.5mL Table 4. Major Company of 40ug/0.5mL Table 5. Major Company of 60ug/0.5mL Table 6. Global Darbepoetin Alpha Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Darbepoetin Alpha Injection Sales by Type (2021-2026) & (K Units) Table 8. Global Darbepoetin Alpha Injection Sales Market Share in Volume by Type (2021-2026) Table 9. Global Darbepoetin Alpha Injection Sales by Type (2021-2026) & (US$ Million) Table 10. Global Darbepoetin Alpha Injection Sales Market Share in Value by Type (2021-2026) Table 11. Global Darbepoetin Alpha Injection Price by Type (2021-2026) & (US$/Unit) Table 12. Global Darbepoetin Alpha Injection Sales by Type (2027-2032) & (K Units) Table 13. Global Darbepoetin Alpha Injection Sales Market Share in Volume by Type (2027-2032) Table 14. Global Darbepoetin Alpha Injection Sales by Type (2027-2032) & (US$ Million) Table 15. Global Darbepoetin Alpha Injection Sales Market Share in Value by Type (2027-2032) Table 16. Global Darbepoetin Alpha Injection Price by Type (2027-2032) & (US$/Unit) Table 17. North America Darbepoetin Alpha Injection Sales by Type (2021-2026) & (K Units) Table 18. North America Darbepoetin Alpha Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Darbepoetin Alpha Injection Sales by Type (2021-2026) & (K Units) Table 20. Europe Darbepoetin Alpha Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Darbepoetin Alpha Injection Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Darbepoetin Alpha Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Darbepoetin Alpha Injection Sales by Type (2021-2026) & (K Units) Table 24. Latin America Darbepoetin Alpha Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Darbepoetin Alpha Injection Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Darbepoetin Alpha Injection Sales by Type (2021-2026) & (US$ Million) Table 27. Darbepoetin Alpha Injection Industry Trends Table 28. Darbepoetin Alpha Injection Industry Drivers Table 29. Darbepoetin Alpha Injection Industry Opportunities and Challenges Table 30. Darbepoetin Alpha Injection Industry Restraints Table 31. Global Darbepoetin Alpha Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Darbepoetin Alpha Injection Revenue Market Share by Company (2021-2026) Table 33. Global Darbepoetin Alpha Injection Sales by Company (2021-2026) & (K Units) Table 34. Global Darbepoetin Alpha Injection Sales Share by Company (2021-2026) Table 35. Global Darbepoetin Alpha Injection Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Darbepoetin Alpha Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Darbepoetin Alpha Injection Major Company Production Sites and Headquarters Table 38. Global Darbepoetin Alpha Injection Company, Product Type & Application Table 39. Global Darbepoetin Alpha Injection Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Darbepoetin Alpha Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Darbepoetin Alpha Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Darbepoetin Alpha Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Darbepoetin Alpha Injection Sales Market Share in Volume by Region (2021-2026) Table 45. Global Darbepoetin Alpha Injection Sales by Region (2021-2026) & (US$ Million) Table 46. Global Darbepoetin Alpha Injection Sales Market Share in Value by Region (2021-2026) Table 47. Global Darbepoetin Alpha Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Darbepoetin Alpha Injection Sales by Region (2027-2032) & (K Units) Table 49. Global Darbepoetin Alpha Injection Sales Market Share in Volume by Region (2027-2032) Table 50. Global Darbepoetin Alpha Injection Sales by Region (2027-2032) & (US$ Million) Table 51. Global Darbepoetin Alpha Injection Sales Market Share in Value by Region (2027-2032) Table 52. Global Darbepoetin Alpha Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Darbepoetin Alpha Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Darbepoetin Alpha Injection Sales by Application (2021-2026) & (K Units) Table 55. Global Darbepoetin Alpha Injection Sales Market Share in Volume by Application (2021-2026) Table 56. Global Darbepoetin Alpha Injection Sales by Application (2021-2026) & (US$ Million) Table 57. Global Darbepoetin Alpha Injection Sales Market Share in Value by Application (2021-2026) Table 58. Global Darbepoetin Alpha Injection Price by Application (2021-2026) & (US$/Unit) Table 59. Global Darbepoetin Alpha Injection Sales by Application (2027-2032) & (K Units) Table 60. Global Darbepoetin Alpha Injection Sales Market Share in Volume by Application (2027-2032) Table 61. Global Darbepoetin Alpha Injection Sales by Application (2027-2032) & (US$ Million) Table 62. Global Darbepoetin Alpha Injection Sales Market Share in Value by Application (2027-2032) Table 63. Global Darbepoetin Alpha Injection Price by Application (2027-2032) & (US$/Unit) Table 64. North America Darbepoetin Alpha Injection Sales by Application (2021-2026) & (K Units) Table 65. North America Darbepoetin Alpha Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Darbepoetin Alpha Injection Sales by Application (2021-2026) & (K Units) Table 67. Europe Darbepoetin Alpha Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Darbepoetin Alpha Injection Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Darbepoetin Alpha Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Darbepoetin Alpha Injection Sales by Application (2021-2026) & (K Units) Table 71. Latin America Darbepoetin Alpha Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Darbepoetin Alpha Injection Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Darbepoetin Alpha Injection Sales by Application (2021-2026) & (US$ Million) Table 74. Kyowa Kirin Company Information Table 75. Kyowa Kirin Business Overview Table 76. Kyowa Kirin Darbepoetin Alpha Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Kyowa Kirin Darbepoetin Alpha Injection Product Portfolio Table 78. Kyowa Kirin Recent Development Table 79. Jiangsu Hengrui Medicine Company Information Table 80. Jiangsu Hengrui Medicine Business Overview Table 81. Jiangsu Hengrui Medicine Darbepoetin Alpha Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Jiangsu Hengrui Medicine Darbepoetin Alpha Injection Product Portfolio Table 83. Jiangsu Hengrui Medicine Recent Development Table 84. Amgen Company Information Table 85. Amgen Business Overview Table 86. Amgen Darbepoetin Alpha Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Amgen Darbepoetin Alpha Injection Product Portfolio Table 88. Amgen Recent Development Table 89. Torii Pharmaceutical Company Information Table 90. Torii Pharmaceutical Business Overview Table 91. Torii Pharmaceutical Darbepoetin Alpha Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Torii Pharmaceutical Darbepoetin Alpha Injection Product Portfolio Table 93. Torii Pharmaceutical Recent Development Table 94. Qilu Pharmaceutical Company Information Table 95. Qilu Pharmaceutical Business Overview Table 96. Qilu Pharmaceutical Darbepoetin Alpha Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Qilu Pharmaceutical Darbepoetin Alpha Injection Product Portfolio Table 98. Qilu Pharmaceutical Recent Development Table 99. Chugai Pharmaceutical Company Information Table 100. Chugai Pharmaceutical Business Overview Table 101. Chugai Pharmaceutical Darbepoetin Alpha Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Chugai Pharmaceutical Darbepoetin Alpha Injection Product Portfolio Table 103. Chugai Pharmaceutical Recent Development Table 104. China Resources Double-Crane Pharmaceutical Company Information Table 105. China Resources Double-Crane Pharmaceutical Business Overview Table 106. China Resources Double-Crane Pharmaceutical Darbepoetin Alpha Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. China Resources Double-Crane Pharmaceutical Darbepoetin Alpha Injection Product Portfolio Table 108. China Resources Double-Crane Pharmaceutical Recent Development Table 109. North America Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. North America Darbepoetin Alpha Injection Sales by Country (2021-2026) & (K Units) Table 111. North America Darbepoetin Alpha Injection Sales Market Share by Country (2021-2026) Table 112. North America Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032) & (K Units) Table 113. North America Darbepoetin Alpha Injection Sales Market Share Forecast by Country (2027-2032) Table 114. North America Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Darbepoetin Alpha Injection Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Darbepoetin Alpha Injection Market Share by Country (2021-2026) Table 117. North America Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Darbepoetin Alpha Injection Market Share Forecast by Country (2027-2032) Table 119. Europe Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Europe Darbepoetin Alpha Injection Sales by Country (2021-2026) & (K Units) Table 121. Europe Darbepoetin Alpha Injection Sales Market Share by Country (2021-2026) Table 122. Europe Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032) & (K Units) Table 123. Europe Darbepoetin Alpha Injection Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Darbepoetin Alpha Injection Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Darbepoetin Alpha Injection Market Share by Country (2021-2026) Table 127. Europe Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Darbepoetin Alpha Injection Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Darbepoetin Alpha Injection Sales by Country (2021-2026) & (K Units) Table 131. Asia-Pacific Darbepoetin Alpha Injection Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032) & (K Units) Table 133. Asia-Pacific Darbepoetin Alpha Injection Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Darbepoetin Alpha Injection Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Darbepoetin Alpha Injection Market Share by Country (2021-2026) Table 137. Asia-Pacific Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Darbepoetin Alpha Injection Market Share Forecast by Country (2027-2032) Table 139. Latin America Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Latin America Darbepoetin Alpha Injection Sales by Country (2021-2026) & (K Units) Table 141. Latin America Darbepoetin Alpha Injection Sales Market Share by Country (2021-2026) Table 142. Latin America Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032) & (K Units) Table 143. Latin America Darbepoetin Alpha Injection Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Darbepoetin Alpha Injection Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Darbepoetin Alpha Injection Market Share by Country (2021-2026) Table 147. Latin America Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Darbepoetin Alpha Injection Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Darbepoetin Alpha Injection Sales by Country (2021-2026) & (K Units) Table 151. Middle East and Africa Darbepoetin Alpha Injection Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032) & (K Units) Table 153. Middle East and Africa Darbepoetin Alpha Injection Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Darbepoetin Alpha Injection Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Darbepoetin Alpha Injection Market Share by Country (2021-2026) Table 157. Middle East and Africa Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Darbepoetin Alpha Injection Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Darbepoetin Alpha Injection Distributors List Table 162. Darbepoetin Alpha Injection Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Darbepoetin Alpha Injection Image Figure 2. Global Darbepoetin Alpha Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Darbepoetin Alpha Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Darbepoetin Alpha Injection Sales (2021-2032) & (K Units) Figure 5. 10ug/0.5mL Image Figure 6. Global 10ug/0.5mL Sales YoY Growth (2021-2032) & (K Units) Figure 7. 20ug/0.5mL Image Figure 8. Global 20ug/0.5mL Sales YoY Growth (2021-2032) & (K Units) Figure 9. 30ug/0.5mL Image Figure 10. Global 30ug/0.5mL Sales YoY Growth (2021-2032) & (K Units) Figure 11. 40ug/0.5mL Image Figure 12. Global 40ug/0.5mL Sales YoY Growth (2021-2032) & (K Units) Figure 13. 60ug/0.5mL Image Figure 14. Global 60ug/0.5mL Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Darbepoetin Alpha Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Darbepoetin Alpha Injection Market Share by Type 2025 VS 2032 Figure 17. North America Darbepoetin Alpha Injection Sales Market Share in Volume by Type in 2025 Figure 18. North America Darbepoetin Alpha Injection Sales Market Share in Value by Type in 2025 Figure 19. Europe Darbepoetin Alpha Injection Sales Market Share in Volume by Type in 2025 Figure 20. Europe Darbepoetin Alpha Injection Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Darbepoetin Alpha Injection Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Darbepoetin Alpha Injection Sales Market Share in Value by Type in 2025 Figure 23. Latin America Darbepoetin Alpha Injection Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Darbepoetin Alpha Injection Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Darbepoetin Alpha Injection Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Darbepoetin Alpha Injection Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Darbepoetin Alpha Injection Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Darbepoetin Alpha Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Darbepoetin Alpha Injection Market Share by Application 2025 VS 2032 Figure 37. North America Darbepoetin Alpha Injection Sales Market Share in Volume by Application in 2025 Figure 38. North America Darbepoetin Alpha Injection Sales Market Share in Value by Application in 2025 Figure 39. Europe Darbepoetin Alpha Injection Sales Market Share in Volume by Application in 2025 Figure 40. Europe Darbepoetin Alpha Injection Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Darbepoetin Alpha Injection Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Darbepoetin Alpha Injection Sales Market Share in Value by Application in 2025 Figure 43. Latin America Darbepoetin Alpha Injection Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Darbepoetin Alpha Injection Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Darbepoetin Alpha Injection Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Darbepoetin Alpha Injection Sales Market Share in Value by Application in 2025 Figure 47. North America Darbepoetin Alpha Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Darbepoetin Alpha Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Darbepoetin Alpha Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Darbepoetin Alpha Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Darbepoetin Alpha Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Darbepoetin Alpha Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Darbepoetin Alpha Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Darbepoetin Alpha Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Darbepoetin Alpha Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Darbepoetin Alpha Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Darbepoetin Alpha Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Darbepoetin Alpha Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Darbepoetin Alpha Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Darbepoetin Alpha Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Darbepoetin Alpha Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Darbepoetin Alpha Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Darbepoetin Alpha Injection Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Darbepoetin Alpha Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 10ug/0.5mL
  • 20ug/0.5mL
  • 30ug/0.5mL
  • 40ug/0.5mL
  • 60ug/0.5mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Kyowa Kirin
  • Jiangsu Hengrui Medicine
  • Amgen
  • Torii Pharmaceutical
  • Qilu Pharmaceutical
  • Chugai Pharmaceutical
  • China Resources Double-Crane Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Darbepoetin Alpha Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Darbepoetin Alpha Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Darbepoetin Alpha Injection Market by Type
  6. 1.3.1 10ug/0.5mL
  7. 1.3.2 20ug/0.5mL
  8. 1.3.3 30ug/0.5mL
  9. 1.3.4 40ug/0.5mL
  10. 1.3.5 60ug/0.5mL
  11. 1.4 Global Darbepoetin Alpha Injection Market Size by Type
  12. 1.4.1 Global Darbepoetin Alpha Injection Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Darbepoetin Alpha Injection Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Darbepoetin Alpha Injection Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Darbepoetin Alpha Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Darbepoetin Alpha Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Darbepoetin Alpha Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Darbepoetin Alpha Injection Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Darbepoetin Alpha Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Darbepoetin Alpha Injection Industry Trends
  2. 2.2 Darbepoetin Alpha Injection Industry Drivers
  3. 2.3 Darbepoetin Alpha Injection Industry Opportunities and Challenges
  4. 2.4 Darbepoetin Alpha Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Darbepoetin Alpha Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Darbepoetin Alpha Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Darbepoetin Alpha Injection Price (2021-2026)
  4. 3.4 Global Darbepoetin Alpha Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Darbepoetin Alpha Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Darbepoetin Alpha Injection Company, Product Type & Application
  7. 3.7 Global Darbepoetin Alpha Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Darbepoetin Alpha Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Darbepoetin Alpha Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Darbepoetin Alpha Injection Tier 1, Tier 2, and Tier 3
4 Darbepoetin Alpha Injection Regional Status and Outlook
  1. 4.1 Global Darbepoetin Alpha Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Darbepoetin Alpha Injection Historic Market Size by Region
  3. 4.2.1 Global Darbepoetin Alpha Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Darbepoetin Alpha Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Darbepoetin Alpha Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Darbepoetin Alpha Injection Forecasted Market Size by Region
  7. 4.3.1 Global Darbepoetin Alpha Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Darbepoetin Alpha Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Darbepoetin Alpha Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Darbepoetin Alpha Injection by Application
  1. 5.1 Darbepoetin Alpha Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Darbepoetin Alpha Injection Market Size by Application
  6. 5.2.1 Global Darbepoetin Alpha Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Darbepoetin Alpha Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Darbepoetin Alpha Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Darbepoetin Alpha Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Darbepoetin Alpha Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Darbepoetin Alpha Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Darbepoetin Alpha Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Darbepoetin Alpha Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Kyowa Kirin
  2. 6.1.1 Kyowa Kirin Company Information
  3. 6.1.2 Kyowa Kirin Business Overview
  4. 6.1.3 Kyowa Kirin Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Kyowa Kirin Darbepoetin Alpha Injection Product Portfolio
  6. 6.1.5 Kyowa Kirin Recent Developments
  7. 6.2 Jiangsu Hengrui Medicine
  8. 6.2.1 Jiangsu Hengrui Medicine Company Information
  9. 6.2.2 Jiangsu Hengrui Medicine Business Overview
  10. 6.2.3 Jiangsu Hengrui Medicine Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu Hengrui Medicine Darbepoetin Alpha Injection Product Portfolio
  12. 6.2.5 Jiangsu Hengrui Medicine Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Amgen Darbepoetin Alpha Injection Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Torii Pharmaceutical
  20. 6.4.1 Torii Pharmaceutical Company Information
  21. 6.4.2 Torii Pharmaceutical Business Overview
  22. 6.4.3 Torii Pharmaceutical Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Torii Pharmaceutical Darbepoetin Alpha Injection Product Portfolio
  24. 6.4.5 Torii Pharmaceutical Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Darbepoetin Alpha Injection Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 Chugai Pharmaceutical
  32. 6.6.1 Chugai Pharmaceutical Company Information
  33. 6.6.2 Chugai Pharmaceutical Business Overview
  34. 6.6.3 Chugai Pharmaceutical Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Chugai Pharmaceutical Darbepoetin Alpha Injection Product Portfolio
  36. 6.6.5 Chugai Pharmaceutical Recent Developments
  37. 6.7 China Resources Double-Crane Pharmaceutical
  38. 6.7.1 China Resources Double-Crane Pharmaceutical Company Information
  39. 6.7.2 China Resources Double-Crane Pharmaceutical Business Overview
  40. 6.7.3 China Resources Double-Crane Pharmaceutical Darbepoetin Alpha Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 China Resources Double-Crane Pharmaceutical Darbepoetin Alpha Injection Product Portfolio
  42. 6.7.5 China Resources Double-Crane Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Darbepoetin Alpha Injection Sales by Country
  2. 7.1.1 North America Darbepoetin Alpha Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Darbepoetin Alpha Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Darbepoetin Alpha Injection Market Size by Country
  6. 7.2.1 North America Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Darbepoetin Alpha Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Darbepoetin Alpha Injection Sales by Country
  2. 8.1.1 Europe Darbepoetin Alpha Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Darbepoetin Alpha Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Darbepoetin Alpha Injection Market Size by Country
  6. 8.2.1 Europe Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Darbepoetin Alpha Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Darbepoetin Alpha Injection Sales by Country
  2. 9.1.1 Asia-Pacific Darbepoetin Alpha Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Darbepoetin Alpha Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Darbepoetin Alpha Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Darbepoetin Alpha Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Darbepoetin Alpha Injection Sales by Country
  2. 10.1.1 South America Darbepoetin Alpha Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Darbepoetin Alpha Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Darbepoetin Alpha Injection Market Size by Country
  6. 10.2.1 South America Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Darbepoetin Alpha Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Darbepoetin Alpha Injection Sales by Country
  2. 11.1.1 Middle East and Africa Darbepoetin Alpha Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Darbepoetin Alpha Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Darbepoetin Alpha Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Darbepoetin Alpha Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Darbepoetin Alpha Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Darbepoetin Alpha Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Darbepoetin Alpha Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Darbepoetin Alpha Injection Value Chain Analysis
  2. 12.1.1 Darbepoetin Alpha Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Darbepoetin Alpha Injection Production Mode & Process
  7. 12.2 Darbepoetin Alpha Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Darbepoetin Alpha Injection Distributors
  10. 12.2.3 Darbepoetin Alpha Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst